A shadow economy for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.
Investigational Treatment Gaining Traction Online
The experimental drug, which remains in research studies, is being advertised by online personalities for its supposed weight-reducing effects. Viewers are encouraged to message these accounts directly for source information, while also receiving promotional offers.
Active Trade on Messaging Platforms
Separately, a robust market exists on Telegram, where groups with numerous of participants share “before and after” photos, administration instructions and assertions of next-day British shipping. Vendors promote the substance there before directing customers to WhatsApp for purchases.
Learning About Retatrutide
Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.
Healthcare Experts Express Concerns
However, physicians and chemists have warned that the sale of what remains an unlicensed drug in the United Kingdom is a cause for concern and could lead to individuals administering products of unknown origin.
Several professionals stated the demand for retatrutide could be connected to the increasing price of licensed slimming products such as Mounjaro.
Regulatory Status and Implementation
Selling the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unapproved drug that must not be promoted or supplied for personal consumption under the British medical regulations.
Some content creators attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still violate medicines, advertising, and customer laws, potentially leading to penalties, legal action or imprisonment.
Platform Response and Material Removal
Based on the social media company, the platform has taken down problematic material and prohibited associated keywords and search suggestions. The company said it was dedicated to maintaining the service safe and allocating resources in strengthening enforcement strategies.
Online Trading Activities
Investigations also discovered communities with up to nine thousand members marketing the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly displays groups with thousands of members, filled with images of weight loss, glowing testimonials and step-by-step guides for preparing or injecting at residence.
After minutes of joining one community, a vendor shared WhatsApp details, where the majority of transactions occur. The vendor provided an guidebook and guaranteed delivery within two days. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None asked about body mass, health issues or past usage.
Item Details and Pricing
Inside these groups, posts show dark colored packages with postal service stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at residence with sterile water, or pre-filled pens usually priced at 160 pounds for 20mg. When asked how long a pen should last, vendors give contradictory answers ranging from a several days to “depends on your body”.
Platform Oversight and Safety Actions
A spokesperson for Telegram stated it regularly moderated dangerous material on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are administering materials they cannot confirm. Although the science behind this drug is valid, these online versions may not contain what they claim,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.
A medical professional of an online medical service linked the surge in interest to recent price rises for authorized slimming medications such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the environment they were made in was clean,” she said.
Her staff has already encountered patients harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be impure or improperly measured.”
Manufacturer Statement
A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a Lilly experimental product not yet authorized … may subject patients to possibly significant medical dangers”.
